Encouragingly, PD-1/PD-L1 blockade has shown promising capacity to increase the proliferation and function of tumor-infiltrating CD8+ T cells, and enhance the antitumor efficacy in several cancer types49–52. The gene discussed is CD8A; the disease is neoplasm.